The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus
The DOI matches its Crossref record.
Abstract
The neuronal dopamine transporter/uptake site can be covalently labeled with the photoaffinity probe 1‐(2‐[bis‐(4‐fluorophenyl)methoxy]ethyl)‐4‐[2‐(4‐azido‐3‐[125 I]iodophenyl)ethyl]piperazine ([125 I]FAPP) and visualized following sodium dodecyl sulfate polyacrylamide gel electrophoresis and autoradiography. Upon photolysis, [125 I]FAPP specifically incorporated into a polypeptide of apparent M r= 62,000 in membranes from both the putamen and the caudate nucleus of control, Alzheimer's, schizophrenia, and Huntington's diseased brain, and, following complete deglycosylation, migrated as an M r∼48,000 polypeptide. In parkinsonian postmortem putamen, however, there was no detectable photoincorpqration of [125 I]FAPP into the ligand binding subunit of the dopamine transporter. [125 I]FAPP did specifically label the Mr 62,000 polypeptide of parkinsonian caudate, although with efficiencies of 20–50% of control. The asymmetrical loss of the dopamine transporter in Parkinson's diseased striatum was confirmed in reversible receptor binding experiments using [3 H]GBR‐12935 {3 H‐labeled 1‐[2‐(diphenylmethoxy)ethyl]‐4‐(3‐phenylpropyl)piperazine}. In parkinsonian putamen, mazindol competitively inhibited the binding of [3 H]GBR‐12935 with an estimated affinity (Ki∼ 2,000 n M) 10 times lower than in controls (Ki∼ 30 n M), while the affinity of mazindol for [3 H]GBR‐12935 binding in the caudate was equal to that seen with controls (Ki∼ 50 n M). The proportion of [3 H]GBR‐12935 binding sites recognized by mazindol with high affinity in Parkinson's diseased caudate was, however, reduced by 50–80%. Taken together, these data clearly suggest that (a) the dopamine transporter is not detectable in Parkinson's diseased putamen, (b) [3 H]GBR‐12935 binding in the putamen of Parkinson's diseased brain is probably not to the dopamine uptake carrier, and (c) there is an interregional variation in the loss of dopamine uptake sites (lost in putamen and somewhat spared in caudate), which appears to parallel markedly the reported loss of dopamine content in idiopathic Parkinson's diseased striatum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Benamer, H. T. S., Patterson, J., Grosset, D. G., Booij, J., de Bruin, K., van Royen, E., Speelman, J. D., Horstink, M. H. I. M., Sips, H. J. W. A., Dierckx, R. A., et al. (2000) · Movement Disorders · doi:10.1002/1531-8257(200005)15:3<503::aid-mds1013>3.0.co;2-v · Cited by 707
The dopamine transporter: immunochemical characterization and localization in brain
Ciliax, B., Heilman, C., Demchyshyn, L., Pristupa, Z., Ince, E., Hersch, S., Niznik, H., & Levey, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01714.1995 · Cited by 589
Self-citationSesack, S. R., Hawrylak, V. A., Matus, C., Guido, M. A., & Levey, A. I. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02697.1998 · Cited by 582
Przedbroski, S., Leviver, M., Jiang, H., Ferreira, M., Jackson-Lewis, V., Donaldson, D., & Togasaki, D. M. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00066-r · Cited by 453
Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders
DeKosky, S. T., & Marek, K. (2003) · Science · doi:10.1126/science.1090349 · Cited by 406
Metadata
- Authors
- Niznik, H. B., Fogel, E. F., Fassos, F. F., & Seeman, P.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1991-01
- Volume
- 56
- Issue
- 1
- Pages
- 192-198
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2063242294
- Cited by
- 154
- References
- 0
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus. https://app.cochat.ai/papers/10.1111/j.1471-4159.1991.tb02580.x
- The paper
- Niznik, H. B., Fogel, E. F., Fassos, F. F., & Seeman, P. (1991). The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1991.tb02580.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.